Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina

2014-09-24 15:14:26 | BioPortfolio

Published on BioPortfolio: 2014-09-24T15:14:26-0400

Clinical Trials [197 Associated Clinical Trials listed on BioPortfolio]

Statin Therapy In Patients With Vasospastic Angina

The purpose of this study is to evaluate whether statin is effective in the treatment of vasospastic angina.

Efficacy Study of Atorvastatin to Treat Variant Angina

The objective of this study is to evaluate effect of statin treatment for vasospastic angina.

Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness

Cilostazol is an antiplatelet agent used to reduce the symptoms of intermittent claudication. Cilostazol inhibits phosphodiesterase III (PDE III), which causes it to be a vasodilator and i...

Cilostazol After Lower Extremity Arterial Revascularization Trial

Ten patients will be recruited to CLEAR. Five will be randomized to the treatment arm (Cilostazol) and five will be randomized to the control group. Patients randomized to the treatment ar...

Effect of Amlodipine Versus Amlodipine Combined With Atorvastatin on the Coronary Vasospastic Angina

The aim of the present study is to compare the effects of CCB and CCB+ high dose of statin therapy on the symptoms, function, and quality of life assessed by validated angina-specific ques...

PubMed Articles [112 Associated PubMed Articles listed on BioPortfolio]

A case report of Brugada-like ST-segment elevation probably due to coronary vasospasm.

Vasospastic angina is caused by sudden occlusive vasoconstriction of a segment of an epicardial artery, with transient ST-segment elevation on electrocardiography. Brugada Syndrome is an inherited arr...

The Rho(ad)-kinase for individualized treatment of vasospastic angina.

Association Between Alcohol Use and Angina Symptoms Among Outpatients From the Veterans Health Administration.

Alcohol use is associated with angina incidence, but associations between alcohol use and experience of angina among patients with coronary artery disease (CAD) have not been described.

Coronary Adventitial and Perivascular Adipose Tissue Inflammation in Patients With Vasospastic Angina.

Recent studies suggested that perivascular components, such as perivascular adipose tissue (PVAT) and adventitial vasa vasorum (VV), play an important role as a source of various inflammatory mediato...

Cilostazol attenuates intimal hyperplasia in a mouse model of chronic kidney disease.

Intimal hyperplasia (IH) is a common cause of vasculopathy due to direct endothelial damage (such as post-coronary revascularization) or indirect injury (such as chronic kidney disease, or CKD). Altho...

Medical and Biotech [MESH] Definitions

ANGINA PECTORIS or angina-like chest pain with a normal coronary arteriogram and positive EXERCISE TEST. The cause of the syndrome is unknown. While its recognition is of clinical importance, its prognosis is excellent. (Braunwald, Heart Disease, 4th ed, p1346; Jablonski Dictionary of Syndromes & Eponymic Diseases, 2d ed). It is different from METABOLIC SYNDROME X, a syndrome characterized by INSULIN RESISTANCE and HYPERINSULINEMIA, that has increased risk for cardiovascular disease.

A vasodilator used in angina of effort or ischemic heart disease.

Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION.

2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis.

A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.

More From BioPortfolio on "Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina"

Quick Search


Searches Linking to this Trial